Is a complete NSE/AAREYDRUGS research report available?

No complete published report is available for nse/AAREYDRUGS (NSE/AAREYDRUGS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

NSE/AAREYDRUGS (NSE/AAREYDRUGS)

National Stock Exchange of India: NSE/AAREYDRUGS · INR

₹75.6

-1.54 (-2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NSE/AAREYDRUGS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.2B
Revenue (ttm)	4.7B
Net income (ttm)	39.7M
EPS (ttm)	₹1.39
P/E (trailing)	54.5x
Volume	7,240
Beta	1.12

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.7B
Net income (ttm): 39.7M
EPS (ttm): ₹1.39
P/E (trailing): 54.5x
Market cap: 2.2B

All NSE/AAREYDRUGS indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

INR

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	132
Enterprise value	INR 2.7B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.56
Industry PE Fwd	34.31
Isin	INE198H01019
Last refreshed	2026-07-30
Market cap	INR 2.2B
Price	INR 75.61
Price currency	INR
Rev Per Employee	35,777,954.55x
Sector	Healthcare
Sector PE	46.2
Sector PE Fwd	37.69
Sic	2833
Symbol	nse/AAREYDRUGS
Website	https://www.aareydrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.84%
EV Earnings	68.94x
EV/EBIT	63.33x
EV/EBITDA	38.14x
EV/Sales	0.58x
FCF yield	-1.05%
P/B ratio	1.44x
P/E ratio	54.48x
P/S ratio	0.46x
PE Ratio10 Y	23.31x
PE Ratio3 Y	38.35x
PE Ratio5 Y	30.17x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.91%
EBITDA Margin	1.52%
Gross margin	3.76%
Gross Profit	INR 177.6M
Gross Profit Growth	50.23%
Gross Profit Growth3 Y	5.59%
Gross Profit Growth5 Y	5.43%
Net Income	INR 39.7M
Net Income Growth	-1.4%
Net Income Growth Q	231.29%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	1.71%
Net Income Growth5 Y	-9.44%
Pretax Margin	1.15%
Profit Margin	0.84%
Profit Per Employee	INR 300,576
Profitable Quarters	INR 16
Profitable Years	19
ROA	0.92
Roa5y	1.65
ROCE	2.84
ROE	2.75
Roe5y	3.78
ROIC	1.56
Roic5y	3.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	17.42%
Cagr3y	31.82%
EPS Growth	-2.11
EPS Growth Q	251.6
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-2.07
EPS Growth5 Y	-12.98
OCF Growth	-1.57%
OCF Growth10 Y	6%
OCF Growth5 Y	13.11%
Revenue Growth	-0.35x
Revenue Growth Q	75.28x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	4.07x
Revenue Growth5 Y	6.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.61
Assets	INR 3B
Cash	INR 34M
Current Assets	INR 2.6B
Current Liabilities	INR 1.5B
Debt	INR 607.5M
Debt EBITDA	INR 8.47
Debt Equity	INR 0.4
Debt FCF	INR -26.74
Equity	INR 1.5B
Interest Coverage	0.86
Liabilities	INR 1.5B
Long Term Assets	INR 343M
Long Term Liabilities	INR 17.5M
Net Cash	INR -573.5M
Net Cash By Market Cap	INR -26.53
Net Debt EBITDA	INR 8
Net Debt Equity	INR 0.38
Tangible Book Value	INR 1.5B
Tangible Book Value Per Share	INR 52.86
WACC	9.44

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.81
Inventory Turnover	8.03
Net Working Capital	INR 1.7B
Quick ratio	0.92
Working Capital	INR 1.2B
Working Capital Turnover	INR 4.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	17.41%
200-day SMA	77.97
3Y total return	129.12%
50-day SMA	81.44
50-day SMA vs 200-day SMA	50over200
All Time High	100
All Time High Change	-24.39%
All Time High Date	2025-11-06
All Time Low	22
All Time Low Change	243.68%
All Time Low Date	2023-03-27
ATR	2.38
Beta	1.12
Ch YTD	11.73
High	76.01
High52	100
High52 Date	2025-11-06
High52ch	-24.39%
Low	75.61
Low52	50.31
Low52 Date	2026-03-30
Low52ch	50.29%
Ma50ch	-7.16%
Price vs 200-day SMA	-3.02%
RSI	38.56
RSI Monthly	53
RSI Weekly	48.54
Sharpe ratio	0.45x
Sortino ratio	0.76
Total Return	-0.71%
Tr YTD	11.73
Tr1m	-18.26%
Tr1w	-0.49%
Tr3m	-20.57%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 43.2M
Operating Income Growth	-15.56
Operating Income Growth3 Y	-13.58
Operating Income Growth5 Y	-12.1
Operating margin	0.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,228,101%
Net Borrowing	-376,000
Shares Insiders	39.03%
Shares Institutions	2.78%
Shares Qo Q	0%
Shares Yo Y	0.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	15,614.3x
Bv Per Share	52.86
CAPEX	INR -124.1M
Ch1m	-18.26
Ch1w	-0.49
Ch1y	17.41
Ch3m	-20.57
Ch3y	129.1
Ch6m	6.88
Change	-2%
Change From Open	-0.53
Close	77.15
Days Gap	-1.48
Depreciation Amortization	28,530,000
Dollar Volume	547,416.4
Earnings Date	2026-08-13
EBIT	INR 43.2M
EBITDA	INR 71.7M
EPS	INR 1.39
F Score	8
FCF	INR -22.7M
FCF EV Yield	-0.83x
Financing CF	21,969,000
Fiscal Year End	March
Founded	1,990
Graham Number	40.53235
Graham Upside	-46.39
Income Tax	INR 14.5M
Investing CF	-124,108,000
Is Primary Listing	0
Last Earnings Date	2026-05-29
Last Report Date	2026-03-31
Lynch Fair Value	INR 6.94
Lynch Upside	-90.82
Ma150	75.17
Ma150ch	0.58%
Ma20	80.13
Ma20ch	-5.64%
Net CF	-747,000
Next Earnings Date	2026-08-13
Open	76.01
P OCF Ratio	21.32
Position In Range	0
Ppne	257,784,000
Price Date	2026-07-29
Price EBITDA	INR 30.14
Ptbv Ratio	1.44
Relative Volume	0.47x
Revenue	4,722,690,000x
Tax By Revenue	0.31x
Tax Rate	26.72%
Tr6m	6.88%
Volume	7,240

NSE/AAREYDRUGS (NSE/AAREYDRUGS)

Coverage state: Market snapshot only — no published research

Generate the first NSE/AAREYDRUGS analysis

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/AAREYDRUGS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/AAREYDRUGS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NSE/AAREYDRUGS

Frequently asked questions